Trials / Recruiting
RecruitingNCT07176416
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
Assessment of Effective Phaco Time and Endothelial Cell Loss When Using a Novel Dual Mode Phacoemulsification System
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Aloha Vision Consultants · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is a single center, prospective study of cumulative dissipated energy and endothelial cells loss per phacoemulsification procedure after successful cataract surgery. Subjects will be assessed 3 months postoperatively at a single visit. Clinical evaluations will include central corneal thickness, specular microscopy, as well as measurement of visual acuities at distance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Veritas Vision System | Veritas Vision System |
Timeline
- Start date
- 2025-10-03
- Primary completion
- 2026-10-01
- Completion
- 2026-10-01
- First posted
- 2025-09-16
- Last updated
- 2025-10-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07176416. Inclusion in this directory is not an endorsement.